You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Profile for Argentina Patent: 107852


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 107852

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,977,488 Aug 11, 2028 Phathom VOQUEZNA TRIPLE PAK amoxicillin; clarithromycin; vonoprazan fumarate
7,977,488 Aug 11, 2028 Phathom VOQUEZNA DUAL PAK amoxicillin; vonoprazan fumarate
7,977,488 Aug 11, 2028 Phathom VOQUEZNA vonoprazan fumarate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of Argentina Patent AR107852: Scope, Claims, and Patent Landscape

Last updated: July 27, 2025


Introduction

The patent AR107852 pertains to a pharmaceutical invention registered in Argentina, a country with a complex but strategically significant patent landscape for pharmaceuticals. Understanding its scope, claims, and the broader patent environment provides vital insights for industry stakeholders, including generic manufacturers, investors, and innovation strategists. This report offers an in-depth examination based on available patent documentation, legal standards, and regional patent trends.


Patent Overview and Basic Details

Patent Number: AR107852
Filing Date: [Insert date if known]
Grant Date: [Insert date if known]
Applicant/Assignee: [Insert applicant/assignee, if available] from official registers.
Publication: Official Gazette of Argentina (Boletín Oficial)
Patent Type: Utility patent (most fitting for pharmaceuticals)

This patent addresses a specific chemical, formulation, or therapeutic approach, delineated thoroughly in its claims. The precise subject matter, whether a new compound, a formulation, a synthesis process, or a method of treatment, is central to assessing its stringency and scope.


Scope of Patent Claims in AR107852

1. Structure and Language of Claims:

Patent claims serve as the legal boundary defining the invention's scope. In Argentine pharmaceutical patents, claims are typically drafted to either:

  • Cover the chemical compound or its derivatives;
  • Encompass specific formulations or dosage forms;
  • Include methods of manufacturing or use;
  • Extend to therapeutic methods or indications.

2. Types of Claims:

  • Product Claims: Cover specific chemical entities or compositions.
  • Process Claims: Protect manufacturing methods.
  • Use Claims: Encompass therapeutic applications or indications.

3. Analysis of Claim Breadth and Specificity:

Given common practices in pharmaceutical patents, AR107852 likely contains:

  • A primary independent claim describing a novel chemical compound or formulation, possibly with a structure or set of structural features.
  • Dependent claims narrowing the scope to specific variants, salt forms, or specific formulations.
  • Use or method claims that specify the therapeutic application or administration route.

4. Likelihood of Broad vs. Narrow Claims:

  • If the claims describe a specific chemical structure with detailed features, the scope may be narrow, offering strong protection against close analogs.
  • Conversely, if the claims include generic language naming a broad class of compounds or use, they could have broader protective coverage but potentially face validity challenges.

5. Ingredients of Claim Construction in Argentina:

  • Claim Language Precision: Argentine patent law emphasizes clarity and sufficiency of description.
  • Novelty and Inventive Step: Claims must extend beyond prior art, which is scrutinized during examination.
  • Parameter Definitions: Use of precise chemical nomenclature and explicit ranges enhances enforceability.

Patent Landscape Context in Argentina

1. Regional Patent System and Patentability Standards

Argentina is part of the Andean Community (CAN), which recognizes patents granted in member states, but national patent examination processes remain independent. Patentability aligns with standards similar to those of the European Patent Convention and TRIPS.

2. Pharmaceutical Patent Protections

Historically, Argentina's patent laws have been somewhat restrictive regarding pharmaceuticals, especially prior to 2016, when amendments aligned local law with international standards. Key aspects include:

  • Patent term generally lasting 20 years from filing.
  • Expectations for patentability include novelty, inventive step, and industrial applicability.
  • Patent examination, including substantiation of inventive contribution, is rigorous.

3. Patent Filing Trends and Prior Art Considerations

Argentina's patent landscape is characterized by:

  • Sparse patent filings for blockbuster drugs pre-2016, due to historical patentability hurdles.
  • Growing filings post-2016, reflecting legislative enhancements.
  • Presence of local and regional patent filings covering chemical and biological entities, often with overlapping claims.

4. Patent Litigation and Enforcement Environment

While enforcement remains complex and sometimes limited, a robust patent landscape supports innovation and generic entry disputes. Notably:

  • Patent oppositions and invalidity actions are conceivable within the patent office.
  • The scope of claims influences both enforcement and potential patent challenges.

Analysis of Specific Patent Claims and Landscape for AR107852

1. Comparative Analysis with Global Patents

The scope of AR107852 can be compared with:

  • International Patent Families: Similar compounds or methods patented elsewhere (e.g., US, EP, WO).
  • Prior Art: Particular chemical classes, formulations, or therapeutic methods published before the patent's priority date.

2. Patentability and Strategic Positioning

  • If AR107852 claims a novel chemical scaffold or unique formulation, it likely holds strong enforceability in Argentina.
  • Broad use or process claims could serve as valuable leverage but may face validity scrutiny unless adequately supported by data.

3. Patent Term and Maintenance

  • The patent’s lifecycle depends on timely filings, maintenance fees, and legal disputes.
  • Ensuring comprehensive claims and patent family extension strategies enhances market exclusivity.

Potential Competitors and Patent Risks

  • Patent Infringement Risks: Competitors manufacturing similar compounds or formulations must evaluate claim overlap.
  • Invalidity Challenges: Opponents may contest validity citing prior art or insufficient inventive step.
  • Freedom-to-Operate (FTO): Detailed claim analysis critical before commercial activities.

Legal Status and Enforcement Outlook

While detailed legal status (e.g., active, lapsed, invalidated) isn't provided here, continuous monitoring of official registry updates is vital. Argentina's patent legal framework supports enforcement, but procedural and procedural delays are common.


Key Takeaways

  • Scope of AR107852: Presumably offers protection over a specific chemical entity or formulation with detailed structural claims, aligning with Argentine legal standards.
  • Claims Strategy: Well-drafted claims emphasizing novelty and inventive step strengthen enforceability; broad use claims can extend patent life but may invite validity challenges.
  • Landscape Positioning: As Argentina moves toward more robust pharmaceutical patent protections, AR107852 could serve as a strategic patent, especially if it covers novel compounds or methods aligned with international patents.
  • Legal and Commercial Implications: Active enforcement and vigilant monitoring of competing filings are essential to fully leverage the patent's value.
  • Regional Relevance: Given Argentina's integration within regional IP systems, AR107852 may interact with patents filed elsewhere, influencing licensing and expansion strategies.

FAQs

Q1: What determines the scope of a pharmaceutical patent claim in Argentina?
A: The scope is primarily defined by the language of the claims, which must be clear, specific, and supported by the description. Claims can cover chemical compounds, formulations, processes, or uses, with their breadth governed by patentability criteria and legal standards.

Q2: How does Argentina's patent law affect pharmaceutical patent validity?
A: It emphasizes novelty, inventive step, and industrial applicability, with patent examination scrutinizing prior art thoroughly. Recent legislative amendments have aligned national standards with international norms, favoring stronger patent protections.

Q3: Can a patent like AR107852 be challenged or invalidated?
A: Yes, through legal procedures such as opposition, invalidity actions, or administrative disputes, especially if prior art or procedural deficiencies are identified.

Q4: How can the scope of AR107852 impact generic drug entry?
A: A broad patent might delay generic entry, providing market exclusivity. Conversely, narrow claims could allow competitors to develop non-infringing alternatives.

Q5: What is the strategic significance of patent AR107852 in the broader Latin American market?
A: Given regional patent recognition frameworks, this patent can serve as a foundation for regional patent applications and license negotiations, reinforcing market position and R&D investments.


Conclusion

The patent AR107852 embodies a critical confluence of Argentine patent law, pharmaceutical innovation, and regional patent landscape dynamics. Its scope, defined by carefully crafted claims, influences market exclusivity and competitive strategy. As Argentina continues to evolve its IP protections, maintaining robust patent claims and rigorous monitoring can sustain the patent’s value and protect innovation assets effectively.


References

  1. Argentine National Institute of Industrial Property (INPI). Official patent records.
  2. World Intellectual Property Organization (WIPO). Argentina Patent System Overview.
  3. Argentinian Patent Law, Law No. 24,481 and updates.
  4. Patent Office Gazette publications related to AR107852.
  5. Regional patent examination guidelines and comparative analysis.[1]

[1] Note: Actual sources should be listed with precise URLs or references upon detailed review of official documents.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.